ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
JPMorgan Downgrades Intrexon (XON) to Neutral
August 11, 2015 7:55 AM EDTJPMorgan downgraded Intrexon (NYSE: XON) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Intrexon click here. For more ratings news on Intrexon click here.
Shares of Intrexon closed at $57.68 yesterday.
... MoreMizuho Securities Downgrades Intrexon (XON) to Underperform
August 11, 2015 6:47 AM EDTMizuho Securities downgraded Intrexon (NYSE: XON) from Neutral to Underperform with a price target of $45.00.
Analyst Peter Lawson commented, "We are downgrading XON from Neutral to Underperform. The stock is over 20% above our $45 PT, and while pipelines of collaborators are progressing, we need... More
Intrexon (XON) Tops Q2 EPS by 5c
August 10, 2015 5:21 PM EDTIntrexon (NYSE: XON) reported Q2 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $44.9 million versus the consensus estimate of $55.52 million.
For earnings history and earnings-related data on Intrexon (XON) click here.
... More